ALPHATEC HOLDINGS, INC. Proceeds from Long-term Lines of Credit
ALPHATEC HOLDINGS, INC. (ATEC) reported Proceeds from Long-term Lines of Credit of $42.75 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLongTermLinesOfCredit · last filed 2026-08-04
- ALPHATEC HOLDINGS, INC. proceeds from long-term lines of credit for the quarter ending 2026-06-30 was $40.00M, a 981.08% increase year-over-year.
- ALPHATEC HOLDINGS, INC. proceeds from long-term lines of credit for the quarter ending 2026-03-31 was $2.75M, a 32.87% decline year-over-year.
- ALPHATEC HOLDINGS, INC. proceeds from long-term lines of credit for the quarter ending 2025-12-31 was $2.99M, a 94.33% decline year-over-year.
- ALPHATEC HOLDINGS, INC. proceeds from long-term lines of credit for the quarter ending 2025-09-30 was $3.37M, a 90.03% decline year-over-year.
- ALPHATEC HOLDINGS, INC. proceeds from long-term lines of credit for fiscal 2025 was $14.15M, a 91.91% decline from fiscal 2024.
- ALPHATEC HOLDINGS, INC. proceeds from long-term lines of credit for fiscal 2024 was $174.97M, a 30.58% increase from fiscal 2023.
- ALPHATEC HOLDINGS, INC. proceeds from long-term lines of credit for fiscal 2023 was $134.00M, a 114.40% increase from fiscal 2022.
- ALPHATEC HOLDINGS, INC. proceeds from long-term lines of credit for fiscal 2022 was $62.50M.
| Period end | Proceeds from Long-term Lines of Credit 3 month | Proceeds from Long-term Lines of Credit 6 month | Proceeds from Long-term Lines of Credit 9 month | Proceeds from Long-term Lines of Credit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $40.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $42.75M 10-Q · filed 2026-08-04 | $45.74M derived: sum of 3 quarters · filed 2026-08-04 | $49.11M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $2.75M 10-Q · filed 2026-05-05 | $5.74M derived: sum of 2 quarters · filed 2026-05-05 | $9.11M derived: sum of 3 quarters · filed 2026-05-05 | $12.81M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $2.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $6.36M derived: sum of 2 quarters · filed 2026-02-24 | $10.06M derived: sum of 3 quarters · filed 2026-08-04 | $14.15M 10-K · filed 2026-02-24 |
| 2025-09-30 | $3.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $7.07M derived: sum of 2 quarters · filed 2026-08-04 | $11.16M 10-Q · filed 2025-10-30 | $63.96M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $3.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $7.79M 10-Q · filed 2026-08-04 | $60.59M derived: sum of 3 quarters · filed 2026-08-04 | $94.37M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $4.09M 10-Q · filed 2026-05-05 | $56.89M derived: sum of 2 quarters · filed 2026-05-05 | $90.67M derived: sum of 3 quarters · filed 2026-05-05 | $137.07M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $52.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $86.58M derived: sum of 2 quarters · filed 2026-02-24 | $132.97M derived: sum of 3 quarters · filed 2026-02-24 | $174.97M 10-K · filed 2026-02-24 |
| 2024-09-30 | $33.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $80.17M derived: sum of 2 quarters · filed 2025-10-30 | $122.17M 10-Q · filed 2025-10-30 | $164.18M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $46.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $88.40M 10-Q · filed 2025-07-31 | $130.40M derived: sum of 3 quarters · filed 2026-02-24 | $167.40M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $42.00M 10-Q · filed 2025-05-01 | $84.00M derived: sum of 2 quarters · filed 2026-02-24 | $121.00M derived: sum of 3 quarters · filed 2026-02-24 | |
| 2023-12-31 | $42.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $79.00M derived: sum of 2 quarters · filed 2026-02-24 | $134.00M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $37.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $92.00M 10-Q · filed 2024-10-30 | ||
| 2023-06-30 | $55.00M 10-Q · filed 2024-07-31 | |||
| 2022-12-31 | $27.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $62.50M 10-K · filed 2025-02-26 | ||
| 2022-09-30 | $35.00M 10-Q · filed 2023-11-06 | |||
| 2020-12-31 | $42.45M 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |